Clinical Trials Logo

Clinical Trial Summary

Biomarkers have an interest in clinic diagnostic ,therapeutic and prognosis in pathophysiologic situation including cardiovascular.But interest of biomarkers in diagnostic care of severe acute respiratory insufficiency remains to clear.

We propose to determine the more relevant marker combination in this case.


Clinical Trial Description

In urgence of a severe acute respiratory insufficiency,for thanks to an approach diagnostic, therapeutic and prognostic we propose to determine the more relevant biomarker combination.

An expert committee will compare the biomarker diagnostic and prognostic relevance thanks to all elements clinico-biological and patient monitoring. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00835809
Study type Observational
Source University Hospital, Grenoble
Contact
Status Completed
Phase N/A
Start date October 2008
Completion date October 2009

See also
  Status Clinical Trial Phase
Completed NCT02592512 - NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency N/A
Recruiting NCT04791501 - Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
Completed NCT03358043 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales
Completed NCT01931228 - Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy N/A
Completed NCT03145974 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
Completed NCT01901497 - Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. N/A
Completed NCT00686257 - Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure N/A
Completed NCT02939963 - Ventilation Strategies During Spontaneous Breathing Trial N/A
Completed NCT04346693 - An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 Phase 3